Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 02 2019
Historique:
received: 09 10 2018
accepted: 20 11 2018
pubmed: 30 11 2018
medline: 7 1 2020
entrez: 30 11 2018
Statut: epublish

Résumé

During a measles virus (MeV) epidemic in 2009 in South Africa, measles inclusion body encephalitis (MIBE) was identified in several HIV-infected patients. Years later, children are presenting with subacute sclerosing panencephalitis (SSPE). To investigate the features of established MeV neuronal infections, viral sequences were analyzed from brain tissue samples of a single SSPE case and compared with MIBE sequences previously obtained from patients infected during the same epidemic. Both the SSPE and the MIBE viruses had amino acid substitutions in the ectodomain of the F protein that confer enhanced fusion properties. Functional analysis of the fusion complexes confirmed that both MIBE and SSPE F protein mutations promoted fusion with less dependence on interaction by the viral receptor-binding protein with known MeV receptors. While the SSPE F required the presence of a homotypic attachment protein, MeV H, in order to fuse, MIBE F did not. Both F proteins had decreased thermal stability compared to that of the corresponding wild-type F protein. Finally, recombinant viruses expressing MIBE or SSPE fusion complexes spread in the absence of known MeV receptors, with MIBE F-bearing viruses causing large syncytia in these cells. Our results suggest that alterations to the MeV fusion complex that promote fusion and cell-to-cell spread in the absence of known MeV receptors is a key property for infection of the brain.

Identifiants

pubmed: 30487282
pii: JVI.01700-18
doi: 10.1128/JVI.01700-18
pmc: PMC6364028
pii:
doi:

Substances chimiques

Cell Adhesion Molecules 0
Viral Fusion Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS091263
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS105699
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Immunol. 2001 Nov 15;167(10):6009-14
pubmed: 11698481
J Virol. 2012 Dec;86(23):12838-48
pubmed: 22993149
J Virol. 2013 Mar;87(5):2648-59
pubmed: 23255801
EMBO J. 1987 Mar;6(3):681-8
pubmed: 3582370
mBio. 2015 Feb 10;6(1):
pubmed: 25670774
PLoS Pathog. 2011 Aug;7(8):e1002240
pubmed: 21901103
PLoS Pathog. 2010 Oct 28;6(10):e1001168
pubmed: 21060819
Virol J. 2013 Sep 12;10:283
pubmed: 24025157
J Virol. 1998 Feb;72(2):1224-34
pubmed: 9445022
Protein Expr Purif. 2006 Jul;48(1):61-8
pubmed: 16600625
Nature. 2011 Nov 02;480(7378):530-3
pubmed: 22048310
FEMS Microbiol Rev. 2012 May;36(3):649-62
pubmed: 22316382
J Virol. 2013 Aug;87(16):9208-16
pubmed: 23760251
J Virol. 2013 Jan;87(1):314-26
pubmed: 23077316
Virology. 2001 Dec 20;291(2):215-25
pubmed: 11878891
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Virus Res. 2005 Aug;111(2):132-47
pubmed: 15893837
Cell. 1988 Oct 21;55(2):255-65
pubmed: 3167982
J Biol Chem. 2012 Jan 2;287(1):778-93
pubmed: 22110138
J Virol. 2010 Nov;84(21):11189-99
pubmed: 20719945
PLoS One. 2013;8(2):e55682
pubmed: 23437059
Nucleic Acids Res. 1996 Mar 15;24(6):1171-2
pubmed: 8604354
J Virol. 2015 Mar;89(5):2710-7
pubmed: 25520515
J Virol. 2018 Feb 26;92(6):
pubmed: 29298883
J Virol. 2007 Oct;81(19):10567-74
pubmed: 17652384
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2496-2501
pubmed: 29463726
Curr Opin Virol. 2014 Apr;5:16-23
pubmed: 24492202
Nat Struct Mol Biol. 2011 Feb;18(2):135-41
pubmed: 21217702
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353
Acta Neuropathol. 1998 Dec;96(6):637-42
pubmed: 9845294
Virology. 1992 Jun;188(2):910-5
pubmed: 1585658
PLoS One. 2014 Apr 18;9(4):e95470
pubmed: 24748123
S Afr Med J. 2015 Sep 14;105(9):713-8
pubmed: 26428963
J Virol. 2015 Jan 15;89(2):1143-55
pubmed: 25378493
Virology. 1986 Oct 15;154(1):97-107
pubmed: 3750847
S Afr Med J. 2011 May;101(5):313-4, 316-7
pubmed: 21837871
EMBO J. 2001 Aug 1;20(15):4024-34
pubmed: 11483506
J Virol. 2002 Dec;76(24):13062-8
pubmed: 12438633
Virus Res. 2007 Dec;130(1-2):260-8
pubmed: 17825451
EMBO J. 1998 Jul 15;17(14):3899-908
pubmed: 9670007

Auteurs

Fabrizio Angius (F)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Heidi Smuts (H)

Division of Medical Virology, Department of Pathology, University of Cape Town and National Health Laboratory Service, Cape Town, South Africa.

Ksenia Rybkina (K)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Debora Stelitano (D)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Brian Eley (B)

Paediatric Infectious Diseases Unit, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Jo Wilmshurst (J)

Paediatric Neurology Unit, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Marion Ferren (M)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Alexandre Lalande (A)

CIRI, International Center for Infectiology Research, Inserm, U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.

Cyrille Mathieu (C)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Anne Moscona (A)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, USA.
Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, New York, USA.

Branka Horvat (B)

CIRI, International Center for Infectiology Research, Inserm, U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.

Takao Hashiguchi (T)

Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Matteo Porotto (M)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA mp3509@columbia.edu diana.hardie@uct.ac.za.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.

Diana Hardie (D)

Division of Medical Virology, Department of Pathology, University of Cape Town and National Health Laboratory Service, Cape Town, South Africa mp3509@columbia.edu diana.hardie@uct.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH